TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/03/2024
Back to search
Official data from USPTO
LYSEBLUE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/03/2024
Trademark type
Word
Nice classes
1, 5
Filing date
11/16/2005
Registration date
10/02/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2017
Last transaction
05/03/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Hilden, DE
Examiner
GRIFFIN, JAMES
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
QIAGEN GmbH
QIAGEN GmbH
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposessolutions for protein processingbuffersreagentsindicatorslysis compositionswash compositionsbinding compositionsenzymessolvents for the preparation of samplesthe modification and manipulation of cells as well as performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; diagnostic preparationsexcept for human medical and veterinary medical purposes; reagents and solventsnot for medical or veterinary purposesin particular for the preparation of samplesthe modification and manipulation of cells as well as for performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; kits comprising products for scientific and research diagnostic purposescomposed of solutions for protein processingbuffersreagentsindicatorslysis compositionswash compositionsbinding compositionsenzymessolventsin particular for the preparation of samplesthe modification and manipulation of cells as well as for the markingseparationisolationpurificationreproduction and analysis of biopolymersin particular nucleic acidsproteinsmacromoleculesbiologically active substances in particular nucleic acids from biological and biochemical sample material
Class 5
Products for medical and veterinary medical purposesin particular diagnostic preparationsin particular for the preparation of samplesthe modification and manipulation of cells and for the markingseparationisolationpurification and reproduction and the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; chemicalbiochemical and biotechnological productsin particular reagents and solvents for medical and veterinary use for the preparation of samplesthe modification and the manipulation of cells as well as for performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits comprising products for medical and veterinary medical diagnostic purposes composed of solutions for protein processingbuffersreagentsindicatorslysis compositionswash compositionsbinding compositionsenzymessolventsbinding supportsin particular for the preparation of samplesthe modification and manipulation of cells and for markingseparationisolationpurificationreproduction and analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample material
Publications
History of USPTO decisions and trademark events.
41 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/21/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/21/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/13/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/13/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/13/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
09/11/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/02/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/03/2013
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/03/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/03/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/01/2013
E815
TEAS SECTION 8 & 15 RECEIVED
10/01/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2007
PUBO
PUBLISHED FOR OPPOSITION
07/17/2007
NPUB
NOTICE OF PUBLICATION
06/27/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/03/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/02/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/02/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2007
ALIE
ASSIGNED TO LIE
05/02/2007
PAPER RECEIVED
04/03/2007
GNSL
LETTER OF SUSPENSION E-MAILED
01/11/2007
CNSL
SUSPENSION LETTER WRITTEN
01/11/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/27/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/24/2006
PAPER RECEIVED
11/24/2006
GNRT
NON-FINAL ACTION E-MAILED
05/23/2006
CNRT
NON-FINAL ACTION WRITTEN
05/23/2006
DOCK
ASSIGNED TO EXAMINER
05/16/2006
NWAP
NEW APPLICATION ENTERED
11/22/2005
Continuous trademark protection
Get notified about every new filing that threatens LYSEBLUE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.